Literature DB >> 17044179

The latent process decomposition of cDNA microarray data sets.

Simon Rogers1, Mark Girolami, Colin Campbell, Rainer Breitling.   

Abstract

We present a new computational technique (a software implementation, data sets, and supplementary information are available at http://www.enm.bris.ac.uk/lpd/) which enables the probabilistic analysis of cDNA microarray data and we demonstrate its effectiveness in identifying features of biomedical importance. A hierarchical Bayesian model, called Latent Process Decomposition (LPD), is introduced in which each sample in the data set is represented as a combinatorial mixture over a finite set of latent processes, which are expected to correspond to biological processes. Parameters in the model are estimated using efficient variational methods. This type of probabilistic model is most appropriate for the interpretation of measurement data generated by cDNA microarray technology. For determining informative substructure in such data sets, the proposed model has several important advantages over the standard use of dendrograms. First, the ability to objectively assess the optimal number of sample clusters. Second, the ability to represent samples and gene expression levels using a common set of latent variables (dendrograms cluster samples and gene expression values separately which amounts to two distinct reduced space representations). Third, in constrast to standard cluster models, observations are not assigned to a single cluster and, thus, for example, gene expression levels are modeled via combinations of the latent processes identified by the algorithm. We show this new method compares favorably with alternative cluster analysis methods. To illustrate its potential, we apply the proposed technique to several microarray data sets for cancer. For these data sets it successfully decomposes the data into known subtypes and indicates possible further taxonomic subdivision in addition to highlighting, in a wholly unsupervised manner, the importance of certain genes which are known to be medically significant. To illustrate its wider applicability, we also illustrate its performance on a microarray data set for yeast.

Entities:  

Mesh:

Year:  2005        PMID: 17044179     DOI: 10.1109/TCBB.2005.29

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  14 in total

1.  GLAD: a mixed-membership model for heterogeneous tumor subtype classification.

Authors:  Hachem Saddiki; Jon McAuliffe; Patrick Flaherty
Journal:  Bioinformatics       Date:  2014-09-29       Impact factor: 6.937

2.  Classification of Alzheimer Diagnosis from ADNI Plasma Biomarker Data.

Authors:  Jue Mo; Stuart Maudsley; Bronwen Martin; Sana Siddiqui; Huey Cheung; Calvin A Johnson
Journal:  ACM Conf Bioinform Comput Biol Biomed Inform (2013)       Date:  2013

3.  A marginalized variational bayesian approach to the analysis of array data.

Authors:  Yiming Ying; Peng Li; Colin Campbell
Journal:  BMC Proc       Date:  2008-12-17

4.  Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models.

Authors:  Simon Rogers; Mark Girolami; Walter Kolch; Katrina M Waters; Tao Liu; Brian Thrall; H Steven Wiley
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

5.  Topic modeling for untargeted substructure exploration in metabolomics.

Authors:  Justin Johan Jozias van der Hooft; Joe Wandy; Michael P Barrett; Karl E V Burgess; Simon Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

6.  DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Authors:  Bogdan-Alexandru Luca; Daniel S Brewer; Dylan R Edwards; Sandra Edwards; Hayley C Whitaker; Sue Merson; Nening Dennis; Rosalin A Cooper; Steven Hazell; Anne Y Warren; Rosalind Eeles; Andy G Lynch; Helen Ross-Adams; Alastair D Lamb; David E Neal; Krishna Sethia; Robert D Mills; Richard Y Ball; Helen Curley; Jeremy Clark; Vincent Moulton; Colin S Cooper
Journal:  Eur Urol Focus       Date:  2017-03-06

7.  Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.

Authors:  David Olmos; Daniel Brewer; Jeremy Clark; Daniel C Danila; Chris Parker; Gerhardt Attard; Martin Fleisher; Alison Hm Reid; Elena Castro; Shahneen K Sandhu; Lorraine Barwell; Nikhil Babu Oommen; Suzanne Carreira; Charles G Drake; Robert Jones; Colin S Cooper; Howard I Scher; Johann S de Bono
Journal:  Lancet Oncol       Date:  2012-10-09       Impact factor: 41.316

8.  A factor analysis model for functional genomics.

Authors:  Rafal Kustra; Romy Shioda; Mu Zhu
Journal:  BMC Bioinformatics       Date:  2006-04-21       Impact factor: 3.169

9.  A heuristic approach to determine an appropriate number of topics in topic modeling.

Authors:  Weizhong Zhao; James J Chen; Roger Perkins; Zhichao Liu; Weigong Ge; Yijun Ding; Wen Zou
Journal:  BMC Bioinformatics       Date:  2015-09-25       Impact factor: 3.169

10.  Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques.

Authors:  L Carrivick; S Rogers; J Clark; C Campbell; M Girolami; C Cooper
Journal:  J R Soc Interface       Date:  2006-06-22       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.